News Results
There are 776,790 News Results
Nov 5, 2024
NEW YORK, Nov. 5, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global online doctor consultation market size is estimated to grow by USD 38.87...
Nov 18, 2024
CHENGDU, China, Nov. 18, 2024 /PRNewswire/ -- In November 2024, C Ray Therapeutics (Chengdu) Co., Ltd. (hereinafter referred to as "C Ray"), an innovative enterprise in the field of radiopharmaceuticals,...
Nov 21, 2024
Company Achieved 50% YoY Revenue Growth & Positive EBITDA
Nov 27, 2024
Hydrogen Compressors Market expansion is driven by development of electrochemical hydrogen compressor (EHC), the rising investments in renewable energy & hydrogen generation projects worldwide and increasing shift toward green hydrogen....
Dec 2, 2024
OAKLAND, Calif., Dec. 2, 2024 /PRNewswire/ -- PG&E Corporation (NYSE: PCG) ("PG&E" or the "Company") announced today the launch of concurrent underwritten public offerings of (i) $1,200 million of shares...
Dec 2, 2024
OAKLAND, Calif., Dec. 2, 2024 /PRNewswire/ -- PG&E Corporation (NYSE: PCG) ("PG&E" or the "Company") announced today the pricing of its previously announced concurrent underwritten public offerings of (i) 48,661,800...
Dec 12, 2024
KRAKOW, Poland, Dec. 12, 2024 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that address emerging targets in oncology, provided an...
Dec 13, 2024
The "ADC Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Stage of Development, Process Component, Target Indication, Antibody Generation, Antibody Origin, Antibody Isotype, Type of Payload, Type...
Jan 8, 2025
-- Narrative Review Assesses Current Treatment Challenges and the Evolving Classic Congenital Adrenal Hyperplasia (CAH) Therapeutic Landscape -- Non-Glucocorticoid (GC) Mechanisms for Treatment of CAH Could Enable Control of Excess...
Jan 21, 2025
SAN DIEGO, Jan. 21, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced publication of a classic congenital adrenal hyperplasia (CAH)-focused supplement in
